Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1 Infected Women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa

OBJECTIVE: Maternal-to-child-transmission of HIV-1 infection remains a significant cause of HIV-1 infection despite successful prevention strategies. Testing protective HIV-1 vaccines remains a critical priority. The immunogenicity of ALVAC-HIV vCP1521 (ALVAC) in infants born to HIV-1 infected women...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaleebu, Pontiano, Njai, Harr Freeya, Wang, Lei, Jones, Norman, Ssewanyana, Isaac, Richardson, Paul, Kintu, Kenneth, Emel, Lynda, Musoke, Philippa, Fowler, Mary Glenn, Ou, San-San, Guay, Laura, Andrew, Philip, Baglyos, Lynn, team, Huyen Cao
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171956/
https://ncbi.nlm.nih.gov/pubmed/24091694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.qai.0000435600.65845.31
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items